PhD Monitor
/Detail
Cancer Biology● OpenPostdoc⏰ 7 days leftPreview

Postdoctoral Research Fellow in Therapy Resistance and Molecular Evolution of Acute Myelogenous Leukemia

Explore molecular mechanisms of AML relapse and therapy resistance using cutting-edge molecular techniques in a well-resourced laboratory.

Best for:Best for postdoctoral researchers with a PhD in molecular biology, cancer biology, or a related field, and experience in wet-lab techniques, including molecular and cellular approaches.

University of Michigan · Ann Arbor, United States · R2 · Recognised researcher
More professors at University of Michigan
therapy resistance in AMLmolecular evolution of leukemiagene pathways in cancer relapseAML xenotransplantsmechanistic studies in cancer biology
This is a postdoc position — not a PhD studentship.
Deadline
Oct 21, 2026
7 days
Funding
—
Start date
flexible
Full-time
Location
Ann Arbor
United States

Overview

This postdoctoral position at the University of Michigan focuses on investigating the molecular evolution and therapy resistance in human acute myelogenous leukemia (AML) at relapse. The successful candidate will conduct in-depth mechanistic studies on candidate genes identified by the lab, employing advanced wet-lab molecular, cellular, and in vivo AML xenotransplant approaches. The project leverages extensive preliminary data and access to hundreds of human AML specimens, providing a robust foundation for impactful research. The role is ideal for researchers with a strong background in molecular biology and a passion for advancing cancer biology and potential therapeutic strategies.

postdoctoral researchacute myelogenous leukemia (AML)therapy resistancemolecular biologycancer relapsewet-lab techniquesxenotransplantsmechanistic studies

What you'll do

  • Conduct research into the molecular mechanisms underlying therapy resistance and relapse in acute myelogenous leukemia (AML).
  • Study nominated candidate genes using advanced wet-lab molecular and cellular techniques.
  • Perform in-depth mechanistic investigations on selected genes using in vivo AML xenotransplant models.
  • Analyze and interpret substantial new datasets generated by the lab to identify novel candidate genes.
  • Collaborate with the research team to advance understanding of competitive regrowth of leukemia cells post-therapy.

Requirements

Degree required: Terminal doctoral degree (PhD) or a professional doctorate (e.g., M.D., D.D.S., D.V.M.) in molecular biology, cancer biology, or a related field.

Language: English (proficiency required for communication and documentation)

Instruction: English

Required skills
  • Proven experience in wet-lab molecular and cellular techniques.
  • Familiarity with in vivo AML xenotransplant models.
  • Strong background in molecular biology and cancer research.
  • Documented evidence of prior research productivity.
Nice to have
Experience with advanced molecular techniques such as CRISPR/Cas9 or RNA sequencing.Prior work in cancer biology or related fields.
Eligibility
  • No specific nationality or residency restrictions mentioned.
  • No age or prior experience caps mentioned.

Funding & terms

Type
Unknown
Amount
—
Duration
—
Programme
—

How to apply

Deadline: 2026-10-21

Applicants should follow the application instructions provided on the University of Michigan’s job portal. The process typically involves submitting a CV, cover letter, and other required documents through the designated online application system.

Documents required
  • CV
  • Cover letter
  • Documentation of prior productivity (e.g., publications, conference abstracts)
↗Apply on site
SM
Prof.
Sami Malek
Internal Medicine - Hematology/Oncology
Lab
Laboratory of Dr. Sami Malek
University of Michigan
United States
See the full position

Create a free profile to unlock your personal match score, the full requirements, funding details and how to apply — in English or Persian.

No card · 10 free AI match scores
Ready to apply?
7 days until the deadline — open this position on its website.